Login
Toggle navigation
Videos
Categories
Trending
CAREL Industries Spa's Officer aims to analyze the company's sales strategies, processes, and methodologies.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Francesco Nalini, CAREL Group CEO.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Implementing Servant Leadership: Overcoming Resistance and Driving Change|Joseph DePinto,CEO and President,7-Eleven
00:10:00
AVZ Minerals Highlights World's Largest Lithium Project in Congo at One-to-One Mining Conference
00:10:00
Amanda van Dijk Discusses the Sustainable Resources Fund and Its Role in the Energy Transition at Mining Investment London
00:10:00
Home Bistro Inc.: Exclusive Interview with CEO Zomi Dukkha and Celebrity Chef Dana Falk on Gourmet Meal Delivery Innovations
00:10:00
Insights into Fortinova’s Journey to Nasdaq First North Premier | Anders Johansson, CEO, Fortinova Fastigheter AB.
00:10:00
Delta Resources Updates on Drilling Progress and Treasury Boost
00:10:00
Greenland Minerals: Advancing the World's Most Significant Emerging Rare Earth Project
00:10:00
Defending True Free Market Capitalism: Paul Marshall's Stand at the ARC Conference 2023 | Sir Paul Marshall - Chief Investment Officer and Chairman of Marshall Wace LLP
00:10:00
Brink’s CEO: Conditions for U.S. Marijuana Dispensary Partnership & Industry Opportunities | Douglas A Pertz - CEO of Brink's
00:10:00
Biotech Company CEO Discusses CAM2038 on Stockholm Stock Exchange Listing Day | Fredrik Tiberg, CEO, Camurus AB.
00:10:00
"Leadership in Finance: Marc Rowan's Insights at Norges Bank Investment Management's Annual Investment Conference 2024"
00:10:00
Weijian Shan on Transforming Shenzhen Development Bank and His Journey from Barefoot Doctor to Finance Leader Part-1 | Weijian Shan, CEO, PAG.